According to Cognitive Market Research, the global Stem Cell Assay Market size will be USD 2356.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 18.20% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 942.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.4% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 706.98 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 542.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.2% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 117.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.6% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 47.13 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.9% from 2024 to 2031.
The Regenerative Medicine & Therapy Development category is the fastest growing segment of the Stem Cell Assay industry
